Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

SCNN1B – Pseudohypoaldosteronism Type IB1

Pseudohypoaldosteronism type IB1 is an autosomal recessive salt-wasting disorder characterized by failure to thrive, hyperkalemia, hypovolemia and metabolic acidosis due to reduced epithelial sodium channel activity. A 32-year-old female presented with persistent hyperkalemia, metabolic acidosis and failure to thrive and was found to carry compound heterozygous SCNN1B variants c.1288del (p.Leu430TyrfsTer3) and c.1466+1G>A, confirming the diagnosis (PMID:26807262). This single unrelated proband provides limited genetic evidence, with biallelic loss-of-function alleles likely abolishing β-ENaC function. No functional assays have been reported for these specific β-ENaC variants, although the clinical phenotype is concordant with channel loss-of-function. Additional unrelated cases, segregation data, and in vitro studies are required to substantiate this association. Key take-home: targeted SCNN1B sequencing in neonates with PHA1 phenotype enables accurate diagnosis and guides management of life-threatening electrolyte imbalances.

References

  • Endocrinology, diabetes & metabolism case reports • 2016 • Pseudohypoaldosteronism type 1 due to novel variants of SCNN1B gene. PMID:26807262

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

One unrelated proband with compound heterozygous LoF SCNN1B variants (c.1288del, c.1466+1G>A) ([PMID:26807262])

Genetic Evidence

Limited

Biallelic loss-of-function variants identified in a single proband with no segregation or replication

Functional Evidence

Limited

No published functional assays for β-ENaC SCNN1B PHA1 variants; presumed loss-of-function